vimarsana.com

Latest Breaking News On - Insider transactions at kiniksa pharmaceuticals - Page 1 : vimarsana.com

Wells Fargo & Company Begins Coverage on Kiniksa Pharmaceuticals (NASDAQ:KNSA)

Wells Fargo & Company Begins Coverage on Kiniksa Pharmaceuticals (NASDAQ:KNSA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Sanjk-patel
Kiniksa-pharmaceuticals
Altitude-crest-partners-inc
Jpmorgan-chase-co
Kiniksa-pharmaceuticals-ltd
Peregrine-capital-management
Parkman-healthcare-partners
Kiniksa-pharmaceuticals-stock-down
Connor-clark-lunn-investment-management-ltd
Wells-fargo-company
Granahan-investment-management

Evercore ISI Increases Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30.00

Evercore ISI Increases Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Michaelr-megna
Sanjk-patel
Principal-financial-group-inc
Insider-transactions-at-kiniksa-pharmaceuticals
Securities-exchange-commission
Linden-thomas-advisory-services
China-universal-asset-management-co
Connor-clark-lunn-investment-management-ltd
Kiniksa-pharmaceuticals-stock-performance
Kiniksa-pharmaceuticals-ltd

Linden Thomas Advisory Services LLC Has $2.01 Million Holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)

Linden Thomas Advisory Services LLC cut its position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 1.2% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 114,550 shares of the company’s stock after selling 1,341 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in Kiniksa Pharmaceuticals were worth $2,009,000 as of […]

Sanjk-patel
News-ratings-for-kiniksa-pharmaceuticals-daily
Acadian-asset-management
Connor-clark-lunn-investment-management-ltd
Nasdaq
Schonfeld-strategic-advisors
Quarter-for-kiniksa-pharmaceuticals
Kiniksa-pharmaceuticals-company-profile
Kiniksa-pharmaceuticals-stock
Linden-thomas-advisory-services
Securities-exchange-commission

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Reaches New 1-Year High at $20.94

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $20.94 and last traded at $20.83, with a volume of 197612 shares traded. The stock had previously closed at $20.16. Analyst Upgrades and Downgrades A number of research analysts […]

Johnf-paolini
Michaelr-megna
News-ratings-for-kiniksa-pharmaceuticals-daily
Institutional-trading-of-kiniksa-pharmaceuticals
Kiniksa-pharmaceuticals-ltd
Securities-exchange-commission
Insider-transactions-at-kiniksa-pharmaceuticals
Kiniksa-pharmaceuticals
Morgan-stanley
Blackrock-inc
Nasdaq

Rice Hall James & Associates LLC Sells 9,758 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)

Rice Hall James & Associates LLC Sells 9,758 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
Johnf-paolini
Michaelr-megna
Securities-exchange-commission
Kiniksa-pharmaceuticals
Nasdaq
Lazard-asset-management
Exchange-commission
Altshuler-shaham-ltd
Kiniksa-pharmaceuticals-ltd
Quarter-for-kiniksa-pharmaceuticals
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.